| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919081 | Radiotherapy and Oncology | 2012 | 6 Pages |
Abstract
A high local control rate can be achieved when treating T1-T2 hypopharynx cancers with definitive radiotherapy. The high rate of nodal and distant relapses among patients with N2-N3 disease warrants intensification of therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Pierre Blanchard, Yungan Tao, Ovidiu Veresezan, Antoine Lusinchi, Anne-Marie Le Ridant, François Janot, Nicolas Daly-Schveitzer, Jean Bourhis,